Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3229641
Max Phase: Preclinical
Molecular Formula: C47H67N15O12S2
Molecular Weight: 1098.28
Molecule Type: Protein
Associated Items:
ID: ALA3229641
Max Phase: Preclinical
Molecular Formula: C47H67N15O12S2
Molecular Weight: 1098.28
Molecule Type: Protein
Associated Items:
Canonical SMILES: COc1ccc(C[C@@H]2NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1
Standard InChI: InChI=1S/C47H67N15O12S2/c1-74-27-13-11-26(12-14-27)20-31-43(70)59-32(19-25-7-3-2-4-8-25)42(69)56-30(15-16-36(49)63)41(68)60-33(21-37(50)64)44(71)61-34(24-76-75-23-28(48)39(66)58-31)46(73)62-18-6-10-35(62)45(72)57-29(9-5-17-54-47(52)53)40(67)55-22-38(51)65/h2-4,7-8,11-14,28-35H,5-6,9-10,15-24,48H2,1H3,(H2,49,63)(H2,50,64)(H2,51,65)(H,55,67)(H,56,69)(H,57,72)(H,58,66)(H,59,70)(H,60,68)(H,61,71)(H4,52,53,54)/t28-,29-,30-,31-,32-,33-,34-,35-/m0/s1
Standard InChI Key: SBEJNRRJIUNGOZ-DZCXQCEKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1098.28 | Molecular Weight (Monoisotopic): 1097.4535 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Lowbridge J, Manning M, Seto J, Haldar J, Sawyer WH.. (1979) Synthetic antagonists of in vivo responses by the rat uterus to oxytocin., 22 (5): [PMID:458806] [10.1021/jm00191a019] |
2. Bankowski K, Manning M, Haldar J, Sawyer WH.. (1978) Design of potent antagonists of the vasopressor response to arginine-vasopressin., 21 (9): [PMID:722751] [10.1021/jm00207a002] |
Source(1):